Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
403.82
-9.10 (-2.20%)
Jan 2, 2026, 9:30 AM EST
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $350.68 billion as of January 6, 2026. Its market cap has increased by 51.76% in one year.
Market Cap
350.68B
Enterprise Value
384.71B
Revenue
79.83B
Ranking
n/a
PE Ratio
29.58
Stock Price
$403.82
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 350.68B, an increase of 3,903.83%. That is a compound annual growth rate of 11.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 350.68B | -1.05% |
| Dec 30, 2025 | 354.42B | 56.67% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |